Study on the medication rule of traditional Chinese medicine compound for breast cancer based on national patent
LI Xiaofeng1 LI Jianhui2 BIAN Jingqi3 SONG Aiying4#br#
1.The First Clinical Medical College, Heilongjiang University of Chinese Medicine, Heilongjiang Province, Harbin 150040, China;
2.School of Basic Medicine, Heilongjiang University of Chinese Medicine, Heilongjiang Province, Harbin 150040, China;
3.School of Pharmacy, Heilongjiang University of Chinese Medicine, Heilongjiang Province, Harbin 150040, China;
4.Department of Oncology, the First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Heilongjiang Province, Harbin 150040, China
Abstract:Objective To analyze the national patented compound for the treatment of breast cancer, and to provide references for clinical prescription. Methods All patent granted by the State Intellectual Property Office was retrieved. Excel was used to establish a database, the frequency of traditional Chinese medicine, four qi, five flavor, and meridian were analyzed, SPSS Modeler 18.0 and SPSS Statistics 26.0 were used to analyze association rules, complex networks, and cluster analysis. Results A total of 154 patents were included, involving 499 kinds of traditional Chinese medicine, high frequency drugs were astragalus, angelica, etc.; four qi was mainly cold, five taste was mainly bitter, return to the liver meridian; high frequency medicine had astragalus-angelica; association rules included dangshen-astragalus, etc.; cluster analysis found four combinations of traditional Chinese medicine. Conclusion The treatment of breast cancer with traditional Chinese medicine compound focuses on nourishing deficiency, regulating liver and regulating qi, and fighting cancer.
李小风1 李建辉2 卞敬琦3 宋爱英4. 基于国家专利中药复方治疗乳腺癌用药规律研究[J]. 中国医药导报, 2022, 19(29): 25-28.
LI Xiaofeng1 LI Jianhui2 BIAN Jingqi3 SONG Aiying4. Study on the medication rule of traditional Chinese medicine compound for breast cancer based on national patent. 中国医药导报, 2022, 19(29): 25-28.